Literature DB >> 14561086

Thermal denaturation: a method to rank slow binding, high-affinity P38alpha MAP kinase inhibitors.

Rachel R Kroe1, John Regan, Al Proto, Gregory W Peet, Tapon Roy, Laura D Landro, Natalie G Fuschetto, Christopher A Pargellis, Richard H Ingraham.   

Abstract

It has been reported that the diaryl urea class of p38alpha inhibitors binds to p38 map kinase with both high affinity and slow binding kinetics (Pargellis et al. Nat. Struct. Biol. 2002, 9, 268-272). The slow binding kinetics of this class of inhibitors is believed to be the result of binding to an allosteric pocket adjacent to the p38alpha active site. The use of traditional kinetic and equilibrium methods to measure the binding affinity of this class of compounds has created many challenges for determination of structure-activity relationships (SAR). The thermal denaturation method provides a means of measuring high-affinity interactions. In this paper, the method of thermal denaturation will be described as it has been applied to the diaryl urea class of p38 map kinase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561086     DOI: 10.1021/jm030120s

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Selective inhibitors of methionyl-tRNA synthetase have potent activity against Trypanosoma brucei Infection in Mice.

Authors:  Sayaka Shibata; J Robert Gillespie; Angela M Kelley; Alberto J Napuli; Zhongsheng Zhang; Kuzma V Kovzun; Ranae M Pefley; Jocelyn Lam; Frank H Zucker; Wesley C Van Voorhis; Ethan A Merritt; Wim G J Hol; Christophe L M J Verlinde; Erkang Fan; Frederick S Buckner
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

2.  Discovery of CDK8/CycC Ligands with a New Virtual Screening Tool.

Authors:  Wei Chen; Xiaodong Ren; Chia-En A Chang
Journal:  ChemMedChem       Date:  2018-12-10       Impact factor: 3.466

3.  Enhancing the Anticancer Potential of Targeting Tumor-Associated Metalloenzymes via VEGFR Inhibition by New Triazolo[4,3-a]pyrimidinone Acyclo C-Nucleosides Multitarget Agents.

Authors:  Mohamed Nabil Abd Al Moaty; El Sayed Helmy El Ashry; Laila Fathy Awad; Nihal Ahmed Ibrahim; Marwa Muhammad Abu-Serie; Assem Barakat; Mezna Saleh Altowyan; Mohamed Teleb
Journal:  Molecules       Date:  2022-04-08       Impact factor: 4.927

4.  High-affinity inhibitors of human NAD-dependent 15-hydroxyprostaglandin dehydrogenase: mechanisms of inhibition and structure-activity relationships.

Authors:  Frank H Niesen; Lena Schultz; Ajit Jadhav; Chitra Bhatia; Kunde Guo; David J Maloney; Ewa S Pilka; Minghua Wang; Udo Oppermann; Tom D Heightman; Anton Simeonov
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

5.  A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.

Authors:  Oleg Fedorov; Brian Marsden; Vanda Pogacic; Peter Rellos; Susanne Müller; Alex N Bullock; Juerg Schwaller; Michael Sundström; Stefan Knapp
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

6.  Potent and selective inhibitors of CDPK1 from T. gondii and C. parvum based on a 5-aminopyrazole-4-carboxamide scaffold.

Authors:  Zhongsheng Zhang; Kayode K Ojo; Ramasubbarao Vidadala; Wenlin Huang; Jennifer A Geiger; Suzanne Scheele; Ryan Choi; Molly C Reid; Katelyn R Keyloun; Kasey Rivas; Latha Kallur Siddaramaiah; Kenneth M Comess; Kenneth P Robinson; Philip J Merta; Lemma Kifle; Wim G J Hol; Marilyn Parsons; Ethan A Merritt; Dustin J Maly; Christophe L M J Verlinde; Wesley C Van Voorhis; Erkang Fan
Journal:  ACS Med Chem Lett       Date:  2014-01-09       Impact factor: 4.345

7.  2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site.

Authors:  Benoît Bestgen; Isabelle Krimm; Irina Kufareva; Ahmed Ashraf Moustafa Kamal; Wei-Guang Seetoh; Chris Abell; Rolf W Hartmann; Ruben Abagyan; Claude Cochet; Marc Le Borgne; Matthias Engel; Thierry Lomberget
Journal:  J Med Chem       Date:  2019-02-18       Impact factor: 7.446

8.  Structure-kinetic relationship study of CDK8/CycC specific compounds.

Authors:  Elisabeth V Schneider; Jark Böttcher; Robert Huber; Klaus Maskos; Lars Neumann
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-29       Impact factor: 11.205

9.  The rational design of specific peptide inhibitor against p38α MAPK at allosteric-site: a therapeutic modality for HNSCC.

Authors:  Kamaldeep Gill; Lokesh Nigam; Ratnakar Singh; Suresh Kumar; Naidu Subbarao; Shyam Singh Chauhan; Sharmistha Dey
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

10.  Biochemical and antiparasitic properties of inhibitors of the Plasmodium falciparum calcium-dependent protein kinase PfCDPK1.

Authors:  Keith H Ansell; Hayley M Jones; David Whalley; Alisdair Hearn; Debra L Taylor; Emmanuel C Patin; Timothy M Chapman; Simon A Osborne; Claire Wallace; Kristian Birchall; Jonathan Large; Nathalie Bouloc; Ela Smiljanic-Hurley; Barbara Clough; Robert W Moon; Judith L Green; Anthony A Holder
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.